在未遵守基于准则的妊娠糖尿病查后,围产期结果:基于人口的队列研究
Elizabeth Nethery1, Kelly Pickerill2, Luba Butska2
1Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Acta obstetricia et gynecologica Scandinavica
|March 18, 2025
概括
孕期糖尿病 (GDM) 查在助产士主导的护理中的不遵守与更少的孕期大 (LGA) 婴儿相关,但增加了死胎和孕期小 (SGA) 风险. 这些发现凸显了GDM查遵守的复杂结果.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 公共卫生 公共卫生
背景情况:
- 孕期糖尿病查方法在全球范围内有所不同,加拿大建议普遍查,与瑞典等国家的选择性查形成鲜明对比.
- 加拿大的产前护理模式 (助产士,全科医生,产科医生) 是患者选择的,这可能导致不同的患者群体和查遵守.
- 尽管有普遍的查政策,但在助产士领导的护理机构中,不遵守GDM查更为普遍.
研究的目的:
- 调查在加拿大不列颠哥伦比亚省的助产士领导的产前护理中对GDM查的坚持和不坚持以及产前结果之间的关联.
- 为了比较不良周产期结果的风险,包括对妊娠年龄大 (LGA) 和死产,在怀孕期间与不同的GDM查依从性.
- 探索已知的GDM风险因素是否会改变查依从性和围产期结果之间的关系.
主要方法:
- 一项基于人口的队列研究,利用加拿大不列颠哥伦比亚省的相关行政数据.
- 在助产士主导的护理中包括单独怀孕,重点关注GDM查遵守 (没有测试,早期测试,后期测试) 与正常血糖妊娠.
- 用多变量逻辑二项回归来估计初级 (LGA) 和二次结果的调整风险比率 (aRR),并按GDM风险因素分层.
主要成果:
- 与正常血糖妊娠相比,不坚持 (没有血糖测试) 与LGA (aRR 0.82) 和剖腹产 (aRR 0.75) 的风险降低有关,但死亡出生风险 (aRR 1.6) 和SGA (aRR 1.2) 的风险增加.
- 在具有GDM风险因素且不进行查的怀孕中,死产风险显著增加 (aRR 2.5),而在所有阶层中存在更高的SGA风险.
- 该研究分析了83522例怀孕,为结果评估提供了强大的统计能力.
结论:
- 在助产士主导的护理中,不遵守GDM查指南与一个矛盾的结果相关:胎儿过度生长并发症的风险降低,但死产和SGA的风险增加.
- 这些发现表明,虽然不遵守可能会减轻与宏观性相关的风险,但同时会增加胎儿死亡和生长限制的风险,特别是在高风险的怀孕中.
- 需要进一步的研究,以了解这些关联背后的机制,并优化在不同产前护理模式中的GDM查策略.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes
837
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
837
Diabetes: Symptoms, Diagnosis, and Complications
494
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
494
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Hypoglycemia and Glucagon
146
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
146
Diabetes: Management and Pharmacotherapy
216
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
216


